Skip to main content

Table 9 Adiponectin genotype and polymorphism, CAP, and metabolic parameters in relation to the degree of obesity

From: The association of adiponectin gene polymorphisms with susceptibility and progression of NAFLD in a cohort of Egyptian patients

  Obese (67), N (%) Non obese (19), N (%) P value Mild (30-34.9), N=38, N (%) Moderate (35–39.9), N=19, N (%) Morbid (>40), N=10, N (%) P value
rs266729 CG
Yes 44 (65.67) 9 (47.37) 0.18 25 (65.79) 13 (68.42) 4 (40) 0.9
No 23 (34.33) 10 (52.63) 13 (34.2) 6 (31.58) 6 (60)  
rs3774261 AG
Yes 44 (65.67) 11 (57.9) 0.59 24 (63.16) 14 (73.68) 6 (60) 0.67
No 23 (34.33) 8 (42.1) 14 (36.84) 5 (26.32) 4 (40)
Steatosis
S1 8 (11.9) 8 (42.1) 0.011 5 (13.16) 3 (15.79) 0 (0) 0.43
S2 29 (43.3) 6 (31.6) 19 (50) 6 (31.58) 4 (40)  
S3 30 (44.8) 5 (26.3) 14 (36.84) 10 (52.63) 6 (60)  
  Mean±SD Mean±SD   Mean±SD Mean±SD Mean±SD  
Waist circumference 111 ±10 96 ±8 <0.0001 105 ±7.5 114 ± 8.2 125 ±4.6 <0.0001
BMI 36 ±4.7 27 ±1.9 <0.0001 32 ±1.5 37 ±1.4 45 ±3.6 <0.0001
ALT 44 ± 33 38 ±19 0.97 38 ±33
9–180
30
53 ± 31
18–121
45
47 ±30
8–89
37
0.05
TGS 188 ±105 157 ±82 0.36 167 ±100 230 +118 185 + 83 0.16
Fasting glucose level 98 ±30 95 ±23 0.72 93 ±18 92 ±25 127 ±53 0.0048
AST 41 ±25 35 ±13 0.84 37 ±26 49 ± 23 42 ± 25 0.044